European Journal of Clinical Microbiology

, Volume 3, Issue 5, pp 475–477 | Cite as

Impact of imipenem/cilastatin therapy on faecal flora

  • C. E. Nord
  • L. Kager
  • A. Philipson
  • G. Stiernstedt
Current Topic: Imipenem — A New Carbapenem Antibiotic


To evaluate the effects of parenteral imipenem/cilastatin therapy upon human faecal microflora, stool specimens obtained from ten patients before, during and after therapy were cultured quantitatively for aerobic and anaerobic microorganisms. The patients received 500 mg imipenem combined with 500 mg cilastatin every 6 h for 6–11 days. The antimicrobial therapy was associated with a small decrease in the numbers of enterobacteria, anaerobic cocci and bacteroides during treatment but afterward the microflora normalized in all patients. None of the patients was colonized with new imipenem-resistant bacteria, hadClostridium difficile or cytotoxin in the stools, or developed diarrhoea.


Internal Medicine Antimicrobial Therapy Small Decrease Imipenem Stool Specimen 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Nord, C. E., Heimdahl, A., Kager, L., Malmboig, A. S.: The impact of different antimicrobial agents on the normal gastro-intestinal microflora of humans. Review of Infectious Diseases 1984, 6: 270–275.Google Scholar
  2. 2.
    Kropp, H., Sundelof, J. G., Kalian, J. S., Birnbaum, J.: MK 0787 (N-formimidoyl thienamycin): Evaluation of in vitro and in vivo activities. Antimicrobial Agents and Chemotherapy 1980, 17: 993–1000.PubMedGoogle Scholar
  3. 3.
    Tally, F. P., Jacobus, N. V., Gorbach, S. L.: In vitro activity of N-formimidoyl thienamycin (MK 0787). Antimicrobial Agents and Chemotherapy 1980, 18: 642–644.PubMedGoogle Scholar
  4. 4.
    Alestig, K., Carlberg, H., Nord, C. E., Trollfors, B.: Effect of cefoperazone on faecal flora. Journal of Antimicrobial Chemotherapy 1983, 12: 163–167.PubMedGoogle Scholar
  5. 5.
    Heimdahl, A., Nord, C. E.: Effect of phenoxymethylpenicillin and clindamycin of the oral, throat and faecal microflora of man. Scandinavian Journal of Infectious Diseases 1979, 11: 233–242.PubMedGoogle Scholar
  6. 6.
    Arvidsson, A., Alván, G., Angelin, B., Borgå, O., Nord., C. E.: Ceftriaxone: renal and biliary excretion and effect on the colon microflora. Journal of Antimicrobial Chemotherapy 1982, 10: 207–215.PubMedGoogle Scholar
  7. 7.
    Aronsson, B., Möllby, R., Nord, C. E.:Clostridium difficile and antibiotic-associated diarrhoea in Sweden. Scandinavian Journal of Infectious Diseases 1982, 35: 53–58.PubMedGoogle Scholar
  8. 8.
    Norrby, S. R., Alestig, K., Björnegård, B., Burman, L. Å., Ferber, F., Hubert, J. L., Jones, K. H., Kahan, F. M., Kahan, J. S., Kropp, H., Meisinger, M. A. P., Sundelof, J. G.: Urinary recovery of N-formimidoyl thienamycin (MK 0787) as affected by coadministration of N-formimidoyl thienamycin dehydropeptidase inhibitors. Antimicrobial Agents and Chemotherapy 1983, 23: 300–307.PubMedGoogle Scholar

Copyright information

© Vieweg Publishing 1984

Authors and Affiliations

  • C. E. Nord
    • 1
  • L. Kager
    • 2
  • A. Philipson
    • 3
  • G. Stiernstedt
    • 3
  1. 1.National Bactiological LaboratoryStockholmSweden
  2. 2.Department of SurgeryHuddinge University Hospital, Karolinska InstituteHuddingeSweden
  3. 3.Department of Infectious DiseasesDanderyds Hospital, Karolinska InstituteDanderydSweden

Personalised recommendations